Welcome
Support Centre
12 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN
mRCT
tips on searching
 
 
Information
DUETS

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.


UK trials
Showing records: 3601 to 3610 of 3810
SEARCH FOR RESULTS ORDER DIRECTION MAX RESULTS .
3601 Randomised trial comparing the efficacy of epirubicin, cisplatin and 5-fluorouracil (FEC) to 5-fluorouracil, methotrexate and adriamycin (FAMTX) in patients with gastric and oesophageal cancer
ISRCTN: ISRCTN37398231
Status: Completed
Source of record: UK trials (UK) - subset from ISRCTN Register, UK trials only
3602 A randomised prospective phase III comparison of paclitaxel - carboplatin versus docetaxel - carboplatin as first line chemotherapy in stage Ic-IV epithelial ovarian cancer
ISRCTN: ISRCTN31374767
Status: Completed
Source of record: UK trials (UK) - subset from ISRCTN Register, UK trials only
3603 The effect of rofecoxib on colorectal liver metastases
ISRCTN: ISRCTN29775286
Status: Completed
Source of record: UK trials (UK) - subset from ISRCTN Register, UK trials only
3604 A randomised trial of combination bleomycin, ifosfamide and cisplatinum versus single agent cisplatinum in recurrent cervical cancer
ISRCTN: ISRCTN27785591
Status: Completed
Source of record: UK trials (UK) - subset from ISRCTN Register, UK trials only
3605 A randomised trial of standard anthracycline-based chemotherapy with fluorouracil, epirubicin and cyclophosphamide (FEC) or epirubicin and CMF (Epi-CMF) versus FEC followed by sequential docetaxel as adjuvant treatment for women with early breast cancer
ISRCTN: ISRCTN79718493
Status: Completed
Source of record: UK trials (UK) - subset from ISRCTN Register, UK trials only
3606 Randomised trial of extended antibiotic prophylaxis for fracture fixation and joint replacement: clinical benefits versus ecological risks
ISRCTN: ISRCTN75423827
Status: Completed
Source of record: UK trials (UK) - subset from ISRCTN Register, UK trials only
3607 Clinical trial of oral microemulsion cyclosporin in severe acute ulcerative colitis1
ISRCTN: ISRCTN12342884
Status: Completed
Source of record: UK trials (UK) - subset from ISRCTN Register, UK trials only
3608 Genistein in postmenopausal osteoporosis: a pharmacological study
ISRCTN: ISRCTN74928330
Status: Completed
Source of record: UK trials (UK) - subset from ISRCTN Register, UK trials only
3609 A phase III, prospective randomised comparison of imatinib (STI571, Glivec/Gleevec) 400 mg daily versus imatinib 800 mg daily versus imatinib plus PEG interferon-alpha 2a (Pegasys) in patients with newly-diagnosed chronic phasechronic myeloid leukaemia
ISRCTN: ISRCTN59346371
Status: Ongoing
Source of record: UK trials (UK) - subset from ISRCTN Register, UK trials only
3610 A phase III randomised trial comparing intermittent versus continuous androgen suppression for patients with prostate-specific-antigen (PSA) progression in the clinical absence of distant metastases following radiotherapy for prostate cancer
ISRCTN: ISRCTN22761545
Status: Completed
Source of record: UK trials (UK) - subset from ISRCTN Register, UK trials only
RESULT PAGE
|< < 357 358 359 360 361 362 363 364 365 > >|
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central